₹945.00
Gliclazide Prolonged Release Tablets IP 30 Mg – GLYCRON 30 PR Tablet
Composition – Gliclazide 30 mg prolonged release
Description:
GLYCRON 30 PR contains Gliclazide Prolonged Release Tablets IP 30 mg formulation designed for effective and sustained glycemic control in patients with type 2 diabetes mellitus. It works by stimulating insulin secretion from pancreatic beta cells and improving peripheral insulin utilization. The prolonged release technology ensures consistent drug levels throughout the day, helping in better fasting and postprandial glucose control with reduced risk of sudden fluctuations.
Key Points
Sustained Glycemic Control
Ensures steady and prolonged blood glucose control throughout the day with its prolonged release formulation, helping to avoid wide fluctuations
Effective Fasting and Postprandial Control
Provides comprehensive glycemic management by controlling both fasting and post meal blood glucose levels
Lower Risk of Hypoglycemia
Gradual and controlte-releaseled drug release reduces the chances of sudden drops in blood sugar levels compared to immedia formulations
Enhances Insulin Secretion
Stimulates pancreatic beta cells to increase insulin release and improves overall glycemic regulation
Targeted Specialties
* Diabetology
* General Medicine
* Endocrinology
* Family Physicians
Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.
Related Products
Dapagliflozin 10 mg + Glimipiride 2 mg + Metformin 1000 mg Sustained Release
10*10 Alu-Alu
₹1,790.00
Empagliflozin 12.5 mg + Metformin Hcl 1000 mg
10*10 Blister
₹1,999.00
Glimepiride 3 Mg + Metformin 500 mg + Voglibose 0.3 Mg (Bilayered) Tablets
10*10 BLI
₹1,490.00
Glimepiride 3 mg + Metformin 500 mg
10*10 Blister
₹990.00
